GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93023C00003BARUCH S. BLUMBERG INSTITUTE

Overview

Award facts

Net obligations
$16.24M
$16,240,850of $32.35M potential value
Outlays (paid to date)
$10.78M
$10.78M paid of $16.24M obligated$10,778,648
Period of performance
Nov 15, 2022 to Nov 30, 2027
Ends in 12 months
Modifications
11
Latest action Jul 24, 2026
Contract type
Definitive contract
PIID 75N93023C00003

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.

Dates and value

Award date
Signed on Nov 15, 2022
Current value
$16,240,850Base and exercised options
Potential value (if all options are exercised)
$32,348,261

Obligations by fiscal year of action

  • FY2026: $3,760,574
  • FY2024: $6,986,400
  • FY2023: $5,493,876

Total across 3 fiscal years: $16,240,850

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 24, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationDOYLESTOWN, PA
UEINAYCKSJB7F68
CAGE code47W56
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
Public health and social services emergency fund; National institute of allergy and infectious diseases (0885)Program activities075-0140, 075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Doylestown, Bucks County, Pennsylvania 18902-8400
Congressional district (place of performance)
PA-01As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
10

Solicitation and notices

Solicitation ID
BAA2022-1(as reported)
Solicitation date
Jan 18, 2022

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Nov 15, 2022Base obligation at award: $5,493,876
Latest action
Jul 24, 2026 — Other administrative actionModification P00011; administrative: no change in scope or value
Latest substantive action
May 14, 2026 — Option exercisedModification P00010; obligation change +$3,760,574
Actions by type
  • Base award1
  • Other administrative action6
  • Option exercised3
  • Supplemental agreement (within scope)1
  • Change order1
12 actions recorded, Nov 15, 2022 to Jul 24, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
12

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2024/2024-0885-000
  • 075-2026/2026-0885-000
  • 075-X-0140-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$9,513,876
COVID-19 supplemental outlays
$8,129,459